 | • レポートコード：20QY06-07295 • 出版社/出版日：QYResearch / 2020年6月3日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、141ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、炭疽ワクチンのグローバル市場について種類別（生ワクチン、無細胞PAワクチン）、用途別（人間用、動物用）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・炭疽ワクチン市場の概要 ・世界の主要地域別炭疽ワクチン市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の炭疽ワクチン市場規模2015-2026：種類別（生ワクチン、無細胞PAワクチン） ・世界の炭疽ワクチン市場規模2015-2026：用途別（人間用、動物用） ・炭疽ワクチンの北米市場規模2015-2020 ・炭疽ワクチンのヨーロッパ市場規模2015-2020 ・炭疽ワクチンの中国市場規模2015-2020 ・炭疽ワクチンの日本市場規模2015-2020 ・炭疽ワクチンの東南アジア市場規模2015-2020 ・炭疽ワクチンのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Emergent BioSolutions、Merial、Merck、Zoetis、Bayer Sanidad Animal、Colorado Serum、PharmAthene、Tiankang、Biogénesis-Bago、CAVAC、Rosenbusch、Agrovet、Vecol、CVCRI、IVPM、Prondil、CDV、Indian Immunologicals、Botswana Vaccine Institute、Ceva Santé Animale、Intervac、JOVAC） ・炭疽ワクチンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・炭疽ワクチンの市場動向・機会・課題 ・調査の結論 |
A recently published report by QY Research titled Global Anthrax Vaccines Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Anthrax Vaccines market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Anthrax is a serious disease that can affect both animals and humans. It is caused by bacteria called Bacillus anthracis. People can get anthrax from contact with infected animals, wool, meat, or hides.Anthrax vaccine protects against anthrax disease. Anthrax vaccine was licensed in 1970.Based on limited but sound evidence, the vaccine protects against both cutaneous (skin) and inhalation anthrax.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Anthrax Vaccines market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Anthrax Vaccines industry.
Based on our recent survey, we have several different scenarios about the Anthrax Vaccines YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 586.8 million in 2019. The market size of Anthrax Vaccines will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Anthrax Vaccines market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Anthrax Vaccines market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Anthrax Vaccines market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Anthrax Vaccines market. The report also includes nautical information, where it shows Anthrax Vaccines market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Anthrax Vaccines market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Anthrax Vaccines market.
The classification of Anthrax Vaccines includes Live Vaccines and Cell free PA Vaccines, and the revenue proportion of Live Vaccines in 2016 is about 43%.
Anthrax Vaccines are widely used for human and animal. The most proportion of Anthrax Vaccines is used for animal, and the consumption proportion is about 95.1% in 2016.
South America region is the largest supplier of Anthrax Vaccines, with a production market share nearly 34.7% in 2016. Europe is the second largest supplier of Anthrax Vaccines, enjoying production market share nearly 17.6% in 2016.
South America is the largest sales place, with a sales market share nearly 39.3% in 2016. Following South America, Europe is the second largest sales place with the sales market share of 19.1%.
Geographical Analysis:
Based on region, the global Anthrax Vaccines market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Anthrax Vaccines market are
Emergent BioSolutions
Merial
Merck
Zoetis
Bayer Sanidad Animal
Colorado Serum
PharmAthene
Tiankang
Biogénesis-Bago
CAVAC
Rosenbusch
Agrovet
Vecol
CVCRI
IVPM
Prondil
CDV
Indian Immunologicals
Botswana Vaccine Institute
Ceva Santé Animale
Intervac
JOVAC
Segment by Type
Live Vaccines
Cell free PA Vaccines
Segment by Application
Human Use
Animal Use
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Anthrax Vaccines market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Anthrax Vaccines market.
• The market share of the global Anthrax Vaccines market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Anthrax Vaccines market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Anthrax Vaccines market.
1 Anthrax Vaccines Market Overview
1.1 Anthrax Vaccines Product Scope
1.2 Anthrax Vaccines Segment by Type
1.2.1 Global Anthrax Vaccines Sales by Type (2020-2026)
1.2.2 Live Vaccines
1.2.3 Cell free PA Vaccines
1.3 Anthrax Vaccines Segment by Application
1.3.1 Global Anthrax Vaccines Sales Comparison by Application (2020-2026)
1.3.2 Human Use
1.3.3 Animal Use
1.4 Anthrax Vaccines Market Estimates and Forecasts (2015-2026)
1.4.1 Global Anthrax Vaccines Sales Growth Rate (2015-2026)
1.4.2 Global Anthrax Vaccines Revenue and Growth Rate (2015-2026)
1.4.3 Global Anthrax Vaccines Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Anthrax Vaccines Industry Impact
1.5.1 How the Covid-19 is Affecting the Anthrax Vaccines Industry
1.5.1.1 Anthrax Vaccines Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Anthrax Vaccines Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Anthrax Vaccines Players to Combat Covid-19 Impact
2 Anthrax Vaccines Estimate and Forecast by Region
2.1 Global Anthrax Vaccines Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Anthrax Vaccines Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Anthrax Vaccines Sales Market Share by Region (2015-2020)
2.2.2 Global Anthrax Vaccines Revenue Market Share by Region (2015-2020)
2.3 Global Anthrax Vaccines Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Anthrax Vaccines Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Anthrax Vaccines Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Anthrax Vaccines Estimates and Projections (2015-2026)
2.4.2 Europe Anthrax Vaccines Estimates and Projections (2015-2026)
2.4.3 China Anthrax Vaccines Estimates and Projections (2015-2026)
2.4.4 Japan Anthrax Vaccines Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Anthrax Vaccines Estimates and Projections (2015-2026)
2.4.6 India Anthrax Vaccines Estimates and Projections (2015-2026)
3 Global Anthrax Vaccines Competition Landscape by Players
3.1 Global Top Anthrax Vaccines Players by Sales (2015-2020)
3.2 Global Top Anthrax Vaccines Players by Revenue (2015-2020)
3.3 Global Anthrax Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anthrax Vaccines as of 2019)
3.4 Global Anthrax Vaccines Average Price by Company (2015-2020)
3.5 Manufacturers Anthrax Vaccines Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Anthrax Vaccines Players (Opinion Leaders)
4 Global Anthrax Vaccines Market Size by Type
4.1 Global Anthrax Vaccines Historic Market Review by Type (2015-2020)
4.1.1 Global Anthrax Vaccines Sales Market Share by Type (2015-2020)
4.1.2 Global Anthrax Vaccines Revenue Market Share by Type (2015-2020)
4.1.3 Global Anthrax Vaccines Price by Type (2014-2020)
4.2 Global Anthrax Vaccines Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Anthrax Vaccines Sales Forecast by Type (2021-2026)
4.2.2 Global Anthrax Vaccines Revenue Forecast by Type (2021-2026)
4.2.3 Global Anthrax Vaccines Price Forecast by Type (2021-2026)
5 Global Anthrax Vaccines Market Size by Application
5.1 Global Anthrax Vaccines Historic Market Review by Application (2015-2020)
5.1.1 Global Anthrax Vaccines Sales Market Share by Application (2015-2020)
5.1.2 Global Anthrax Vaccines Revenue Market Share by Application (2015-2020)
5.1.3 Global Anthrax Vaccines Price by Application (2015-2020)
5.2 Global Anthrax Vaccines Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Anthrax Vaccines Sales Forecast by Application (2021-2026)
5.2.2 Global Anthrax Vaccines Revenue Forecast by Application (2021-2026)
5.2.3 Global Anthrax Vaccines Price Forecast by Application (2021-2026)
3 North America Anthrax Vaccines Market Facts & Figures
3.2 North America Anthrax Vaccines Sales Market Share by Company (2015-2020)
3.3 North America Anthrax Vaccines Sales Market Share by Type (2015-2020)
3.4 North America Anthrax Vaccines Sales Market Share by Application (2015-2020)
4 Europe Anthrax Vaccines Market Facts & Figures
4.2 Europe Anthrax Vaccines Sales Market Share by Company (2015-2020)
4.3 Europe Anthrax Vaccines Sales Market Share by Type (2015-2020)
4.4 Europe Anthrax Vaccines Sales Market Share by Application (2015-2020)
5 China Anthrax Vaccines Market Facts & Figures
5.2 China Anthrax Vaccines Sales Market Share by Company (2015-2020)
5.3 China Anthrax Vaccines Sales Market Share by Type (2015-2020)
5.4 China Anthrax Vaccines Sales Market Share by Application (2015-2020)
6 Japan Anthrax Vaccines Market Facts & Figures
6.2 Japan Anthrax Vaccines Sales Market Share by Company (2015-2020)
6.3 Japan Anthrax Vaccines Sales Market Share by Type (2015-2020)
6.4 Japan Anthrax Vaccines Sales Market Share by Application (2015-2020)
7 Southeast Asia Anthrax Vaccines Market Facts & Figures
7.2 Southeast Asia Anthrax Vaccines Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Anthrax Vaccines Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Anthrax Vaccines Sales Market Share by Application (2015-2020)
8 India Anthrax Vaccines Market Facts & Figures
8.2 India Anthrax Vaccines Sales Market Share by Company (2015-2020)
8.3 India Anthrax Vaccines Sales Market Share by Type (2015-2020)
8.4 India Anthrax Vaccines Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Anthrax Vaccines Business
12.1 Emergent BioSolutions
12.1.1 Emergent BioSolutions Anthrax Vaccines Corporation Information
12.1.2 Emergent BioSolutions Anthrax Vaccines Business Overview and Total Revenue
12.1.3 Emergent BioSolutions Anthrax Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Emergent BioSolutions Anthrax Vaccines Products Offered
12.1.5 Emergent BioSolutions Recent Development
12.2 Merial
12.2.1 Merial Anthrax Vaccines Corporation Information
12.2.2 Merial Anthrax Vaccines Business Overview and Total Revenue
12.2.3 Merial Anthrax Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Merial Anthrax Vaccines Products Offered
12.2.5 Merial Recent Development
12.3 Merck
12.3.1 Merck Anthrax Vaccines Corporation Information
12.3.2 Merck Anthrax Vaccines Business Overview and Total Revenue
12.3.3 Merck Anthrax Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Merck Anthrax Vaccines Products Offered
12.3.5 Merck Recent Development
12.4 Zoetis
12.4.1 Zoetis Anthrax Vaccines Corporation Information
12.4.2 Zoetis Anthrax Vaccines Business Overview and Total Revenue
12.4.3 Zoetis Anthrax Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Zoetis Anthrax Vaccines Products Offered
12.4.5 Zoetis Recent Development
12.5 Bayer Sanidad Animal
12.5.1 Bayer Sanidad Animal Anthrax Vaccines Corporation Information
12.5.2 Bayer Sanidad Animal Anthrax Vaccines Business Overview and Total Revenue
12.5.3 Bayer Sanidad Animal Anthrax Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Bayer Sanidad Animal Anthrax Vaccines Products Offered
12.5.5 Bayer Sanidad Animal Recent Development
12.6 Colorado Serum
12.6.1 Colorado Serum Anthrax Vaccines Corporation Information
12.6.2 Colorado Serum Anthrax Vaccines Business Overview and Total Revenue
12.6.3 Colorado Serum Anthrax Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Colorado Serum Anthrax Vaccines Products Offered
12.6.5 Colorado Serum Recent Development
12.7 PharmAthene
12.7.1 PharmAthene Anthrax Vaccines Corporation Information
12.7.2 PharmAthene Anthrax Vaccines Business Overview and Total Revenue
12.7.3 PharmAthene Anthrax Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.7.4 PharmAthene Anthrax Vaccines Products Offered
12.7.5 PharmAthene Recent Development
12.8 Tiankang
12.8.1 Tiankang Anthrax Vaccines Corporation Information
12.8.2 Tiankang Anthrax Vaccines Business Overview and Total Revenue
12.8.3 Tiankang Anthrax Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Tiankang Anthrax Vaccines Products Offered
12.8.5 Tiankang Recent Development
12.9 Biogénesis-Bago
12.9.1 Biogénesis-Bago Anthrax Vaccines Corporation Information
12.9.2 Biogénesis-Bago Anthrax Vaccines Business Overview and Total Revenue
12.9.3 Biogénesis-Bago Anthrax Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Biogénesis-Bago Anthrax Vaccines Products Offered
12.9.5 Biogénesis-Bago Recent Development
12.10 CAVAC
12.10.1 CAVAC Anthrax Vaccines Corporation Information
12.10.2 CAVAC Anthrax Vaccines Business Overview and Total Revenue
12.10.3 CAVAC Anthrax Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.10.4 CAVAC Anthrax Vaccines Products Offered
12.10.5 CAVAC Recent Development
12.11 Rosenbusch
12.11.1 Rosenbusch Anthrax Vaccines Corporation Information
12.11.2 Rosenbusch Anthrax Vaccines Business Overview and Total Revenue
12.11.3 Rosenbusch Anthrax Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Rosenbusch Anthrax Vaccines Products Offered
12.11.5 Rosenbusch Recent Development
12.12 Agrovet
12.12.1 Agrovet Anthrax Vaccines Corporation Information
12.12.2 Agrovet Anthrax Vaccines Business Overview and Total Revenue
12.12.3 Agrovet Anthrax Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Agrovet Anthrax Vaccines Products Offered
12.12.5 Agrovet Recent Development
12.13 Vecol
12.13.1 Vecol Anthrax Vaccines Corporation Information
12.13.2 Vecol Anthrax Vaccines Business Overview and Total Revenue
12.13.3 Vecol Anthrax Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Vecol Anthrax Vaccines Products Offered
12.13.5 Vecol Recent Development
12.14 CVCRI
12.14.1 CVCRI Anthrax Vaccines Corporation Information
12.14.2 CVCRI Anthrax Vaccines Business Overview and Total Revenue
12.14.3 CVCRI Anthrax Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.14.4 CVCRI Anthrax Vaccines Products Offered
12.14.5 CVCRI Recent Development
12.15 IVPM
12.15.1 IVPM Anthrax Vaccines Corporation Information
12.15.2 IVPM Anthrax Vaccines Business Overview and Total Revenue
12.15.3 IVPM Anthrax Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.15.4 IVPM Anthrax Vaccines Products Offered
12.15.5 IVPM Recent Development
12.16 Prondil
12.16.1 Prondil Anthrax Vaccines Corporation Information
12.16.2 Prondil Anthrax Vaccines Business Overview and Total Revenue
12.16.3 Prondil Anthrax Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.16.4 Prondil Anthrax Vaccines Products Offered
12.16.5 Prondil Recent Development
12.17 CDV
12.17.1 CDV Anthrax Vaccines Corporation Information
12.17.2 CDV Anthrax Vaccines Business Overview and Total Revenue
12.17.3 CDV Anthrax Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.17.4 CDV Anthrax Vaccines Products Offered
12.17.5 CDV Recent Development
12.18 Indian Immunologicals
12.18.1 Indian Immunologicals Anthrax Vaccines Corporation Information
12.18.2 Indian Immunologicals Anthrax Vaccines Business Overview and Total Revenue
12.18.3 Indian Immunologicals Anthrax Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.18.4 Indian Immunologicals Anthrax Vaccines Products Offered
12.18.5 Indian Immunologicals Recent Development
12.19 Botswana Vaccine Institute
12.19.1 Botswana Vaccine Institute Anthrax Vaccines Corporation Information
12.19.2 Botswana Vaccine Institute Anthrax Vaccines Business Overview and Total Revenue
12.19.3 Botswana Vaccine Institute Anthrax Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.19.4 Botswana Vaccine Institute Anthrax Vaccines Products Offered
12.19.5 Botswana Vaccine Institute Recent Development
12.20 Ceva Santé Animale
12.20.1 Ceva Santé Animale Anthrax Vaccines Corporation Information
12.20.2 Ceva Santé Animale Anthrax Vaccines Business Overview and Total Revenue
12.20.3 Ceva Santé Animale Anthrax Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.20.4 Ceva Santé Animale Anthrax Vaccines Products Offered
12.20.5 Ceva Santé Animale Recent Development
12.21 Intervac
12.21.1 Intervac Anthrax Vaccines Corporation Information
12.21.2 Intervac Anthrax Vaccines Business Overview and Total Revenue
12.21.3 Intervac Anthrax Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.21.4 Intervac Anthrax Vaccines Products Offered
12.21.5 Intervac Recent Development
12.22 JOVAC
12.22.1 JOVAC Anthrax Vaccines Corporation Information
12.22.2 JOVAC Anthrax Vaccines Business Overview and Total Revenue
12.22.3 JOVAC Anthrax Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.22.4 JOVAC Anthrax Vaccines Products Offered
12.22.5 JOVAC Recent Development
13 Anthrax Vaccines Manufacturing Cost Analysis
13.1 Anthrax Vaccines Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Anthrax Vaccines
13.4 Anthrax Vaccines Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Anthrax Vaccines Distributors List
14.3 Anthrax Vaccines Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Anthrax Vaccines Sales (M Doses) Growth Rate by Type (2020-2026)
Table 2. Global Anthrax Vaccines Sales (M Doses) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Anthrax Vaccines Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Anthrax Vaccines Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Anthrax Vaccines Players to Combat Covid-19 Impact
Table 8. Global Market Anthrax Vaccines Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Anthrax Vaccines Sales (M Doses) by Region (2015-2020)
Table 10. Global Anthrax Vaccines Sales Market Share by Region (2015-2020)
Table 11. Global Anthrax Vaccines Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Anthrax Vaccines Revenue Share by Region (2015-2020)
Table 13. Global Anthrax Vaccines Sales (M Doses) Forecast by Region (2021-2026)
Table 14. Global Anthrax Vaccines Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Anthrax Vaccines Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Anthrax Vaccines Revenue Share Forecast by Region (2021-2026)
Table 17. Global Anthrax Vaccines (M Doses) of Key Companies (2015-2020)
Table 18. Global Anthrax Vaccines Sales Share by Company (2015-2020)
Table 19. Global Anthrax Vaccines Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Anthrax Vaccines Revenue Share by Company (2015-2020)
Table 21. Global Anthrax Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anthrax Vaccines as of 2019)
Table 22. Global Anthrax Vaccines Average Price (USD/K Doses) of Key Company (2015-2020)
Table 23. Manufacturers Anthrax Vaccines Manufacturing Sites and Area Served
Table 24. Manufacturers Anthrax Vaccines Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Anthrax Vaccines Players
Table 27. Global Anthrax Vaccines Sales (M Doses) by Type (2015-2020)
Table 28. Global Anthrax Vaccines Sales Share by Type (2015-2020)
Table 29. Global Anthrax Vaccines Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Anthrax Vaccines Price (M Doses) by Type (2015-2020)
Table 31. Global Anthrax Vaccines Sales Share by Type (2021-2026)
Table 32. Global Anthrax Vaccines Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Anthrax Vaccines Revenue Share by Type (2021-2026)
Table 34. Global Anthrax Vaccines Price (M Doses) by Type (2021-2026)
Table 35. Global Anthrax Vaccines Sales (M Doses) by Application (2015-2020)
Table 36. Global Anthrax Vaccines Sales Share by Application (2015-2020)
Table 37. Global Anthrax Vaccines Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Anthrax Vaccines Price (M Doses) by Application (2015-2020)
Table 39. Global Anthrax Vaccines Sales (M Doses) by Application (2021-2026)
Table 40. Global Anthrax Vaccines Sales Share by Application (2021-2026)
Table 41. Global Anthrax Vaccines Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Anthrax Vaccines Revenue Share by Application (2021-2026)
Table 43. Global Anthrax Vaccines Price (M Doses) by Application (2021-2026)
Table 44. United States Anthrax Vaccines Sales (M Doses) by Company (2015-2020)
Table 45. United States Anthrax Vaccines Sales Market Share by Company (2015-2020)
Table 46. United States Anthrax Vaccines Sales (M Doses) by Type (2015-2020)
Table 47. United States Anthrax Vaccines Sales Market Share by Type (2015-2020)
Table 48. United States Anthrax Vaccines Sales (M Doses) by Application (2015-2020)
Table 49. United States Anthrax Vaccines Sales Market Share by Application (2015-2020)
Table 50. Europe Anthrax Vaccines Sales (M Doses) by Company (2015-2020)
Table 51. Europe Anthrax Vaccines Sales Market Share by Company (2015-2020)
Table 52. Europe Anthrax Vaccines Sales (M Doses) by Type (2015-2020)
Table 53. Europe Anthrax Vaccines Sales Market Share by Type (2015-2020)
Table 54. Europe Anthrax Vaccines Sales (M Doses) by Application (2015-2020)
Table 55. Europe Anthrax Vaccines Sales Market Share by Type (2015-2020)
Table 56. China Anthrax Vaccines Sales (M Doses) by Company (2015-2020)
Table 57. China Anthrax Vaccines Sales Market Share by Company (2015-2020)
Table 58. China Anthrax Vaccines Sales (M Doses) by Type (2015-2020)
Table 59. China Anthrax Vaccines Sales Market Share by Type (2015-2020)
Table 60. China Anthrax Vaccines Sales (M Doses) by Application (2015-2020)
Table 61. China Anthrax Vaccines Sales Market Share by Application (2015-2020)
Table 62. Japan Anthrax Vaccines Sales (M Doses) by Company (2015-2020)
Table 63. Japan Anthrax Vaccines Sales Market Share by Company (2015-2020)
Table 64. Japan Anthrax Vaccines Sales (M Doses) by Type (2015-2020)
Table 65. Japan Anthrax Vaccines Sales Market Share by Type (2015-2020)
Table 66. Japan Anthrax Vaccines Sales (M Doses) by Application (2015-2020)
Table 67. Japan Anthrax Vaccines Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Anthrax Vaccines Sales (M Doses) by Company (2015-2020)
Table 69. Southeast Asia Anthrax Vaccines Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Anthrax Vaccines Sales (M Doses) by Type (2015-2020)
Table 71. Southeast Asia Anthrax Vaccines Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Anthrax Vaccines Sales (M Doses) by Type (2015-2020)
Table 73. Southeast Asia Anthrax Vaccines Sales Market Share by Application (2015-2020)
Table 74. India Anthrax Vaccines Sales (M Doses) by Company (2015-2020)
Table 75. India Anthrax Vaccines Sales Market Share by Company (2015-2020)
Table 76. India Anthrax Vaccines Sales (M Doses) by Type (2015-2020)
Table 77. India Anthrax Vaccines Sales Market Share by Type (2015-2020)
Table 78. India Anthrax Vaccines Sales (M Doses) by Application (2015-2020)
Table 79. India Anthrax Vaccines Sales Market Share by Application (2015-2020)
Table 80. Emergent BioSolutions Corporation Information
Table 81. Emergent BioSolutions Description and Business Overview
Table 82. Emergent BioSolutions Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 83. Emergent BioSolutions Anthrax Vaccines Product
Table 84. Emergent BioSolutions Recent Development
Table 85. Merial Corporation Information
Table 86. Merial Description and Business Overview
Table 87. Merial Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 88. Merial Anthrax Vaccines Product
Table 89. Merial Recent Development
Table 90. Merck Corporation Information
Table 91. Merck Description and Business Overview
Table 92. Merck Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 93. Merck Anthrax Vaccines Product
Table 94. Merck Recent Development
Table 95. Zoetis Corporation Information
Table 96. Zoetis Description and Business Overview
Table 97. Zoetis Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 98. Zoetis Anthrax Vaccines Product
Table 99. Zoetis Recent Development
Table 100. Bayer Sanidad Animal Corporation Information
Table 101. Bayer Sanidad Animal Description and Business Overview
Table 102. Bayer Sanidad Animal Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 103. Bayer Sanidad Animal Anthrax Vaccines Product
Table 104. Bayer Sanidad Animal Recent Development
Table 105. Colorado Serum Corporation Information
Table 106. Colorado Serum Description and Business Overview
Table 107. Colorado Serum Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 108. Colorado Serum Anthrax Vaccines Product
Table 109. Colorado Serum Recent Development
Table 110. PharmAthene Corporation Information
Table 111. PharmAthene Description and Business Overview
Table 112. PharmAthene Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 113. PharmAthene Anthrax Vaccines Product
Table 114. PharmAthene Recent Development
Table 115. Tiankang Corporation Information
Table 116. Tiankang Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 117. Tiankang Description and Business Overview
Table 118. Tiankang Anthrax Vaccines Product
Table 119. Tiankang Recent Development
Table 120. Biogénesis-Bago Corporation Information
Table 121. Biogénesis-Bago Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 122. Biogénesis-Bago Description and Business Overview
Table 123. Biogénesis-Bago Anthrax Vaccines Product
Table 124. Biogénesis-Bago Recent Development
Table 125. CAVAC Corporation Information
Table 126. CAVAC Description and Business Overview
Table 127. CAVAC Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 128. CAVAC Anthrax Vaccines Product
Table 129. CAVAC Recent Development
Table 130. Rosenbusch Corporation Information
Table 131. Rosenbusch Description and Business Overview
Table 132. Rosenbusch Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 133. Rosenbusch Anthrax Vaccines Product
Table 134. Rosenbusch Recent Development
Table 135. Agrovet Corporation Information
Table 136. Agrovet Description and Business Overview
Table 137. Agrovet Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 138. Agrovet Anthrax Vaccines Product
Table 139. Agrovet Recent Development
Table 140. Vecol Corporation Information
Table 141. Vecol Description and Business Overview
Table 142. Vecol Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 143. Vecol Anthrax Vaccines Product
Table 144. Vecol Recent Development
Table 145. CVCRI Corporation Information
Table 146. CVCRI Description and Business Overview
Table 147. CVCRI Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 148. CVCRI Anthrax Vaccines Product
Table 149. CVCRI Recent Development
Table 150. IVPM Corporation Information
Table 151. IVPM Description and Business Overview
Table 152. IVPM Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 153. IVPM Anthrax Vaccines Product
Table 154. IVPM Recent Development
Table 155. Prondil Corporation Information
Table 156. Prondil Description and Business Overview
Table 157. Prondil Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 158. Prondil Anthrax Vaccines Product
Table 159. Prondil Recent Development
Table 160. CDV Corporation Information
Table 161. CDV Description and Business Overview
Table 162. CDV Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 163. CDV Anthrax Vaccines Product
Table 164. CDV Recent Development
Table 165. Indian Immunologicals Corporation Information
Table 166. Indian Immunologicals Description and Business Overview
Table 167. Indian Immunologicals Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 168. Indian Immunologicals Anthrax Vaccines Product
Table 169. Indian Immunologicals Recent Development
Table 170. Botswana Vaccine Institute Corporation Information
Table 171. Botswana Vaccine Institute Description and Business Overview
Table 172. Botswana Vaccine Institute Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 173. Botswana Vaccine Institute Anthrax Vaccines Product
Table 174. Botswana Vaccine Institute Recent Development
Table 175. Ceva Santé Animale Corporation Information
Table 176. Ceva Santé Animale Description and Business Overview
Table 177. Ceva Santé Animale Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 178. Ceva Santé Animale Anthrax Vaccines Product
Table 179. Ceva Santé Animale Recent Development
Table 180. Intervac Corporation Information
Table 181. Intervac Description and Business Overview
Table 182. Intervac Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 183. Intervac Anthrax Vaccines Product
Table 184. Intervac Recent Development
Table . JOVAC Corporation Information
Table . JOVAC Description and Business Overview
Table . JOVAC Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)
Table . JOVAC Anthrax Vaccines Product
Table . JOVAC Recent Development
Table 190. Production Base and Market Concentration Rate of Raw Material
Table 191. Key Suppliers of Raw Materials
Table 192. Anthrax Vaccines Distributors List
Table 193. Anthrax Vaccines Customers List
Table 194. Market Key Trends
Table 195. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 196. Key Challenges
Table 197. Research Programs/Design for This Report
Table 198. Key Data Information from Secondary Sources
Table 199. Key Data Information from Primary Sources
List of Figures
Figure 1. Anthrax Vaccines Product Picture
Figure 2. Global Anthrax Vaccines Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Anthrax Vaccines Market Share by Application in 2020 & 2026
Figure 6. Human Use Examples
Figure 7. Animal Use Examples
Figure 8. Global Anthrax Vaccines Sales (M Doses) Growth Rate (2015-2026)
Figure 9. Global Anthrax Vaccines Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Anthrax Vaccines Price Trends Growth Rate (2015-2026) (USD/K Doses)
Figure 11. Global Anthrax Vaccines Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Anthrax Vaccines Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Anthrax Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Anthrax Vaccines Sales (M Doses) Growth Rate (2015-2026)
Figure 15. Europe Anthrax Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Anthrax Vaccines Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Anthrax Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Anthrax Vaccines Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Anthrax Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Anthrax Vaccines Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Anthrax Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Anthrax Vaccines Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Anthrax Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Anthrax Vaccines Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Anthrax Vaccines Players Market Share by Revenue in Anthrax Vaccines 2015 & 2019
Figure 26. Anthrax Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Anthrax Vaccines Revenue Share by Type (2015-2020)
Figure 28. Global Anthrax Vaccines Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Anthrax Vaccines Revenue Share by Application (2015-2020)
Figure 30. Global Anthrax Vaccines Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Anthrax Vaccines Sales Market Share by Type in 2019
Figure 32. United States Anthrax Vaccines Sales Market Share by Type in 2019
Figure 33. Europe Anthrax Vaccines Sales Market Share by Company in 2019
Figure 34. Europe Anthrax Vaccines Sales Market Share by Type in 2019
Figure 35. Europe Anthrax Vaccines Sales Market Share by Application in 2019
Figure 36. China Anthrax Vaccines Sales Market Share by Company in 2019
Figure 37. China Anthrax Vaccines Sales Market Share by Type in 2019
Figure 38. China Anthrax Vaccines Sales Market Share by Application in 2019
Figure 39. Japan Anthrax Vaccines Sales Market Share by Company in 2019
Figure 40. Japan Anthrax Vaccines Sales Market Share by Type in 2019
Figure 41. Japan Anthrax Vaccines Sales Market Share by Application in 2019
Figure 42. Southeast Asia Anthrax Vaccines Sales Market Share by Company in 2019
Figure 43. Southeast Asia Anthrax Vaccines Sales Market Share by Type in 2019
Figure 44. Southeast Asia Anthrax Vaccines Sales Market Share by Application in 2019
Figure 45. India Anthrax Vaccines Sales Market Share by Company in 2019
Figure 46. India Anthrax Vaccines Sales Market Share by Type in 2019
Figure 47. India Anthrax Vaccines Sales Market Share by Application in 2019
Figure 48. Emergent BioSolutions Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Merial Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Zoetis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Bayer Sanidad Animal Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Colorado Serum Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. PharmAthene Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Tiankang Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Biogénesis-Bago Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. CAVAC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Rosenbusch Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Agrovet Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Vecol Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. CVCRI Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. IVPM Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Prondil Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. CDV Total Revenue (US$ Million): 2019 Compared with 2018
Figure 65. Indian Immunologicals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 66. Botswana Vaccine Institute Total Revenue (US$ Million): 2019 Compared with 2018
Figure 67. Ceva Santé Animale Total Revenue (US$ Million): 2019 Compared with 2018
Figure 68. Intervac Total Revenue (US$ Million): 2019 Compared with 2018
Figure 69. JOVAC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 70. Key Raw Materials Price Trend
Figure 71. Manufacturing Cost Structure of Anthrax Vaccines
Figure 72. Manufacturing Process Analysis of Anthrax Vaccines
Figure 73. Anthrax Vaccines Industrial Chain Analysis
Figure 74. Channels of Distribution
Figure 75. Distributors Profiles
Figure 76. Porter's Five Forces Analysis
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed
H7N9ワクチンの世界市場レポート2020 Market Analysis and Insights: Global H7N9 Vaccines Market The global H7N9 Vaccines market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global H7N9 Vaccines Scope and Market Size The global H7N9 Vaccines market is se…- HPV治療ワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global HPV Therapeutic Vaccines market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The HPV Therapeutic Vacc…
- 鳥インフルエンザワクチンの世界市場レポート2020 A recently published report by QY Research titled Global Avian Influenza Vaccines Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides ac…
- 単純ヘルペスウイルス（HSV）ワクチンの世界市場レポート2020 A recently published report by QY Research titled Global Herpes Simplex Virus (HSV) Vaccines Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically …
- mRNAワクチンおよび治療薬の世界市場レポート2020 mRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically wh…